{"id":"204680631588-97","name":"Aspen Pharmacare","registrationDate":"2018-05-22T11:11:35.626+02:00","category":2,"subCategory":3,"legal":"Holdings Limited","web":"http://aspenpharma.com/","country":"South africa","headAddress":"Building 1, Aspen Park, 98 Armstrong Avenue, La Lucia Ridge, Durban","headCity":"Durban","headPostCode":"Gateway, 4321","headPhone":"(27)03 15 80 86 24","boss":"Naud√© DE KLERK","bossTitle":"Mr","bossPosition":"General Counsel and Head of Legal for Europe CIS (Commercial)","membersCount":1,"membersFTE":"0.25","membership":"https://www.aspenpharma.com/we-care-initiatives/","memberOrga":"https://www.aspenpharma.com/board-of-directors/","goal":"Aspen Pharmacare is a South-African pharmaceutical company. &#xd;<br />Aspen operates with an established business presence in approximately 50 countries and supply products in more than 150 countriesWe have a proud heritage dating back more than 160 years and are committed to sustaining life and promoting healthcare through increasing access to our high quality, affordable medicines and products.&#xd;<br />&#xd;<br />We are a leading global player in specialty and branded pharmaceuticals with an extensive basket of products that provide treatment for a broad spectrum of acute and chronic conditions experienced through all stages of life. We continue to benefit the lives of patients using our products in more than 150 countries.&#xd;<br />&#xd;<br /> Aspen has identified Thrombosis, Anaesthetics, High Potency &amp; Cytotoxics and Nutritionals as our focused therapeutic categories that will receive our highest focus based on materiality and future potential.&#xd;<br />&#xd;<br />We operate 25 manufacturing facilities across 17 sites and we hold international manufacturing approvals from some of the most stringent global regulatory agencies listed here including, among others, the United States Food and Drug Administration, the Australian Therapeutic Goods Administration and the European Directorate for the Quality of Medicines. Our manufacturing capabilities are scaleable to demand and cover a wide variety of product types including oral solid dose, liquids, semi-solids, steriles, biologicals, active pharmaceutical ingredients and nutritionals","acronym":"ASP","interests":"Business and Industry, Communication, External Relations, General and Institutional Affairs, Humanitarian aid and civil protection, International co-operation and development, Public Health, Trade","euInitiatives":"Aspen currently follows European policies, legislative files related to our Pharmaceuticals and any EU project(mainly in Thrombosis, Anesthetesia and Oncology). We are particularly interested in European initiatives to support medicine affordability to patients and any initiatives to support production investment in the European countries. &#xd;<br />Our domains of interest includes also Data Protection Regulation, Brexit consequences, Pharmaceutical Industry strategy, and EU pricing &amp; trade Policy.","lastUp":"2018-05-23T10:29:04.423+02:00","customers":"","costAbsolu":"","costRange":"25000-49999","turnoverAbsolu":0,"turnoverRange":""}